Donders Gilbert G G, Vereecken Annie, Bosmans Eugene, Spitz Bernard
Department of Obstetrics and Gynecology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Herestraat 45, Leuven 3000, Belgium.
Am J Obstet Gynecol. 2003 Nov;189(5):1433-8. doi: 10.1067/s0002-9378(03)00653-7.
The purpose of this study was to determine whether the vaginal cytokine concentration varies during the course of uncomplicated pregnancy.
Prenatal visits of healthy women to University Hospital Gasthuisberg, Leuven, Belgium were considered. Cytokine levels in vaginal washings from 30 unselected healthy women with uncomplicated pregnancies were monitored during pregnancy and compared with those from 62 nonpregnant healthy control subjects. Exclusion criteria included bacterial vaginosis, moderate or severe aerobic vaginitis, Trichomonas vaginalis, Candida vaginitis (wet mount or culture), gonorrhea, and Chlamydia. Interleukin-6, interleukin-8, interleukin-1beta, interleukin-1-receptor antagonist, leukemia inhibitory factor, and tumor necrosis factor were measured. Nonparametric Kruskal-Wallis and Welch tests were used for univariate analysis, and the Spearman rank test was used for multivariate analysis.
Compared with concentrations in nonpregnant women, interleukin-1beta concentrations were similar, but interleukin-1-receptor antagonist production was depressed throughout pregnancy. Vaginal interleukin-6 and interleukin-8 were less often discovered during pregnancy than outside pregnancy and dipped significantly in the middle trimester, to rise again to prepregnancy levels in the third trimester. Leukemia inhibitory factor was lower during the beginning of pregnancy (P=.038) but otherwise did not differ from nonpregnant values throughout pregnancy nor did tumor necrosis factor. Sexual activity could not explain these findings.
Vaginal cytokine levels, especially interleukin-1 receptor antagonist, from pregnant women may differ from nonpregnant values; some levels, such as interleukin-6 and interleukin-8, may fluctuate during normal pregnancy. These spontaneous variations during pregnancy must be taken into account when mucosal immunologic responses to infection of the lower genital tract are being studied.
本研究旨在确定在无并发症的孕期过程中阴道细胞因子浓度是否会发生变化。
纳入比利时鲁汶大学加斯霍伊斯贝格大学医院健康女性的产前检查。对30例未选择的无并发症妊娠的健康女性在孕期进行阴道灌洗,监测细胞因子水平,并与62例非妊娠健康对照者的水平进行比较。排除标准包括细菌性阴道病、中度或重度需氧菌性阴道炎、滴虫性阴道炎、念珠菌性阴道炎(湿片法或培养法)、淋病和衣原体感染。检测白细胞介素-6、白细胞介素-8、白细胞介素-1β、白细胞介素-1受体拮抗剂、白血病抑制因子和肿瘤坏死因子。单因素分析采用非参数Kruskal-Wallis检验和Welch检验,多因素分析采用Spearman秩检验。
与非妊娠女性相比,白细胞介素-1β浓度相似,但整个孕期白细胞介素-1受体拮抗剂的产生受到抑制。孕期阴道白细胞介素-6和白细胞介素-8的检出率低于非孕期,且在孕中期显著下降,在孕晚期再次升至孕前水平。白血病抑制因子在孕早期较低(P = 0.038),但在整个孕期的其他时间与非妊娠时的值无差异,肿瘤坏死因子也无差异。性行为无法解释这些发现。
孕妇阴道细胞因子水平,尤其是白细胞介素-1受体拮抗剂,可能与非妊娠时的值不同;一些水平,如白细胞介素-6和白细胞介素-8,在正常孕期可能会波动。在研究下生殖道感染的黏膜免疫反应时,必须考虑孕期的这些自发变化。